IgE Allergy Blood Tests Market Size & Share, by Product Type {Assays & Kits, ELISA Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemiluminescent Immunoassays (CLIA)}; Application (Aero Allergies, Indoor Allergies, Outdoor Allergies, Food Allergies, Venoms); End-User (Diagnostic Laboratories, Specialty Clinics, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 5551
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

IgE Allergy Blood Tests Market size was valued at USD 31.83 billion in 2024 and is likely to cross USD 63.06 billion by 2037, expanding at more than 5.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of IgE allergy blood tests is estimated at USD 33.29 billion.
 

The major factor influencing the market expansion is the rising prevalence of asthma. With a projected 262.41 million prevalent cases (95% UI 224.05 to 309.45) worldwide, the burden of asthma has continued to climb. Hence, the demand for IgE allergy blood tests is growing. Asthma sufferers undergoing allergy testing typically have their IgE levels checked for airborne allergens that are known to frequently impact their symptoms.

Additionally, there has been growing awareness regarding the prevalence of allergies all across the globe by the government. They are launching various campaigns where they are offering free testing for allergies. This is why, the IgE allergy blood tests market is observing the growth in its revenue. 

IgE Allergy Blood Tests Market O
Discover Market Trends & Growth Opportunities: Request Free Sample PDF


IgE Allergy Blood Tests Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

5.4%

Base Year Market Size (2024)

USD 31.83 billion

Forecast Year Market Size (2037)

USD 63.06 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

IgE Allergy Blood Tests Segmentation

End-User (Diagnostic Laboratories, Specialty Clinics, Hospitals, Research & Academic Centers)

The diagnostics laboratories segment in the IgE allergy blood tests market is estimated to gather the highest share of over 40% during the forecast period. Diagnostic lab services are essential to the healthcare industry since they are vital to the diagnosis and management of diseases. Furthermore, a clear role for the diagnostics laboratory exists in the diagnosis and treatment of allergy sufferers. Furthermore, diagnostics laboratories have a huge availability of funds and the latest technology as compared to hospitals. In the past, when diagnostic testing services were less developed, medical professionals relied on a patient's symptoms to determine what was allegedly wrong and recommend medication. Frequently, the patient's symptoms were ambiguous, and the wrong problem was being addressed. However, this is no longer an issue as a result of developments in technology and medicine. Diagnostic centers today offer several examinations for allergies. As a result, the preference for diagnostics laboratories is growing.

Application (Aero Allergies, Indoor Allergies, Outdoor Allergies, Food Allergies, Venoms, Medicine Allergies, Latex/Metal Allergies)

The food allergies segment is expected to hold 30% share of the global IgE allergy blood tests market during the forecast period. In addition to being obtained through food, vitamin D is produced by the human body when exposed to sunshine. Due in large part to the immune system's regulation by vitamin D, the prevalence of food allergies has risen as vitamin D levels have decreased between nations. According to study data, 50% of the global population suffers from vitamin D insufficiency, while approximately 1 billion people worldwide suffer from vitamin D deficiency.

Our in-depth analysis of the global IgE allergy blood tests market includes the following segments:

     Product Type

  • Assays & Kits
  • ELISA Testing Kits
  • Fluorescent Enzyme Immunoassays (FEIA) Testing Kits
  • Chemiluminescent Immunoassays (CLIA)
  • Reagents, Consumables
  • Analyzers

     Application

  • Aero Allergies, Indoor Allergies
  • Outdoor Allergies
  • Food Allergies
  • Venoms
  • Medicine Allergies
  • Latex/Metal Allergies

     End-User

  • Diagnostic Laboratories
  • Specialty Clinics
  • Hospitals
  • Research & Academic Centers
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.


IgE Allergy Blood Tests Industry - Regional Synopsis

North American Market Forecast

The North America industry is estimated to account for largest revenue share of 30% by 2037. The major element to influence the market expansion is the growing adoption of health insurance. In 2022, more individuals had insurance than in 2021. Moreover, 2022 saw a rise in the proportion of the population with health insurance from 91.7 percent in 2021 to 92.1 percent in 2022 in the US, or 304.0 million individuals, who were insured at some point in the year. Furthermore, for public as well as private sector employees, purchasing a health insurance policy has been made mandatory in various organizations in this region. Key medical benefits are given by health insurance, which employees can use when employed by a business. Health insurance coverage is very helpful in covering treatment costs in the event of an emergency or other medical problem. Additionally, there has been a rise in the development of various instruments by key players for more advanced testing which is also estimated to boost the IgE allergy blood tests market expansion in this region.

APAC Market Analysis

The IgE allergy blood tests market in Asia Pacific is also estimated to have notable growth during the coming years. The market in this region is expanding owing to the increased attention being paid to personalized medication and the expanding knowledge of allergic disorders. The IgE allergy blood tests market growth potential in this region is further enhanced by the incorporation of these tests into standard healthcare regimens.

IgE Allergy Blood Tests Market S
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the IgE Allergy Blood Tests Market

    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis  
    • Eurofins Viracor
    • Neogen Corporation
    • Omega Diagnostics PLC
    • Abionic SA
    • Amerimmune LLC
    • AXO Science
    • Biovator AB
    • China Medical Technologies Inc
    • Cytognos, SL

Recent Developments

  • The U.S. Food & Drug Administration (FDA) has cleared Thermo Fisher Scientific's ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies. These cutting-edge blood tests, which are also anticipated to be made available countrywide, can serve as a diagnostic tool for physicians and other healthcare professionals by assisting in the identification of wheat and sesame allergies in patients who may experience a severe allergic reaction.
  • Leading provider of immunology and infectious disease testing, Eurofins Viracor, officially opened its new, large laboratory in Lenexa, Kansas, today. With 215 current employees and 235 newly created roles, the 110,000 square foot, state-of-the-art facility will employ 450 people and provide additional capacity to support development in biopharma and transplant diagnostic testing services.
  • Report ID: 5551
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of IgE allergy blood tests is estimated at USD 33.29 billion.

The IgE allergy blood tests market size was valued at USD 31.83 billion in 2024 and is likely to cross USD 63.06 billion by 2037, expanding at more than 5.4% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by surge in pollution levels, growing utilization of mHealth, and rising prevalence of food allergies.

North America industry is estimated to account for largest revenue share of 30% by 2037, impelled by growing adoption of health insurance in the region.

The major players in the market are Thermo Fisher Scientific, Inc., Eurofins Viracor, Neogen Corporation, Omega Diagnostics PLC and others.
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.


Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos